AGREEMENTAgreement • February 14th, 2018 • New Leaf Biopharma Opportunities I, L.P. • Pharmaceutical preparations
Contract Type FiledFebruary 14th, 2018 Company IndustryPursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of shares of Common Stock of Sierra Oncology, Inc.
AGREEMENT REGARDING JOINT FILING OF SCHEDULE 13GAgreement Regarding Joint • February 10th, 2021 • New Leaf Biopharma Opportunities I, L.P. • Pharmaceutical preparations
Contract Type FiledFebruary 10th, 2021 Company IndustryPursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of Shares of Addex Therapeutics Ltd.
AGREEMENT REGARDING JOINT FILING OF SCHEDULE 13GAgreement Regarding Joint • February 13th, 2020 • New Leaf Biopharma Opportunities I, L.P. • Pharmaceutical preparations
Contract Type FiledFebruary 13th, 2020 Company IndustryPursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of shares of Common Stock of Sierra Oncology, Inc.
AGREEMENT REGARDING JOINT FILING OF SCHEDULE 13GAgreement Regarding Joint • February 13th, 2019 • New Leaf Biopharma Opportunities I, L.P. • Pharmaceutical preparations
Contract Type FiledFebruary 13th, 2019 Company IndustryPursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of shares of Common Stock of Sierra Oncology, Inc.